We are live on ! Find out more
VXRT

Vaxart

Delisted

VXRT was delisted on the 7th of July, 2025.

100 hedge funds and large institutions have $27M invested in Vaxart in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 22 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 22

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

5.35% less ownership

Funds ownership: 23.17%17.82% (-5.4%)

6% less funds holding

Funds holding: 106100 (-6)

17% less call options, than puts

Call options by funds: $169K | Put options by funds: $204K

48% less capital invested

Capital invested by funds: $52.4M → $27M (-$25.3M)

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
21
Reduced
22
Closed
24
Calls
$169K
Puts
$204K
Net Calls
-$35K
Net Calls Change
-$248K

VXRT Hedge Fund Activity: Q2 2024 in Review

100 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2024, worth a combined $27M — down 48% from $52.4M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of VXRT and 22 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 21 added.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $12.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $20M sold.

  • 100 institutional investors held Vaxart (VXRT) as of Q2 2024, down from 106 in Q1 2024.
  • Funds reported $27M of Vaxart stock for Q2 2024, down 48% quarter-over-quarter.
  • 22 funds opened new Vaxart positions in Q2 2024 and 24 closed out, a net change of -2 holders.
  • The largest Vaxart buyer in Q2 2024 was Sio Capital Management, an estimated $12.3M added.
  • The largest Vaxart seller in Q2 2024 was RA Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2024.